Neonatal Jaundice

Globally, health care providers worldwide recognize that severe neonatal jaundice is a “silent” cause of significant neonatal morbidity and mortality.

0
Over 60% of all newborns develop neonatal jaundice
0
AROUND 15% TO 45% OF NEWBORNS DEVELOP SEVERE NEONATAL JAUNDICE IN DEVELOPING COUNTRIES
0
AROUND 10% OF NEWBORNS DIE DUE TO NEONATAL JAUNDICE ALL OVER THE WORLD
0
ALMOST 20% OF THE JAUNDICE BABIES IN INDIA ALONE ,DIE DUE TO SEVERE NEONATAL JAUNDICE

Challenge

Nearly 13 million infants per year globally are unable to process bilirubin quickly enough and require jaundice treatment to prevent death or lifelong disability.
Even though the cure is simple and this condition preventable, existing solutions are unable to address jaundice of different severities resulting in extended therapy time and morbidity.

SLOW TREATMENT

Methods used currently Delay the treatment to 2-3 weeks. Our goal is to reduce the treatment time significantly

SEVERE JAUNDICE CONDITION

Blood transfusion is a miserable solution for severe jaundice cases. Hence, current indigenous methods of maneuvering with multiple devices are not addressing the need.

POST-NATAL SEPARATION

Just after birth separation of her baby lead to Anxiety and accelerates the postnatal trauma. whereas on the other hand, the newborn loses the advantage of initial bond with its mother.

LOW EFFICIENCY 

The efficiency of the treatment is directly proportional to optimum irradiance, Exposure of Baby Body Surface Area, and sufficient Hydration via Breastfeeding.

SOLUTION

Introducing A smart Design approached technology – A Revolutionary Phototherapy device for neonatal jaundice management.

SMART THERAPY 

The SMART algorithm adds efficiency and helps to reduce prolonged treatment time

HUMAN CENTRIC DESIGN

Our Human Centric Design approach prioritizes Needs of the Newborn in First Place

DESIGNED FOR LOW RESOURCE SETTINGS

Robust design and transformable mechanism support to handle critical conditions in low- resource settings.

KMC & BREASTFEEDING

A flexible design which promotes breastfeeding and Kangaroo Mother Care.

360° TREATMENT

Our Design embraces the baby from 360° which enhances Billurubin disintegration

News

HEAMAC has been featured in…

AWARDS

Akitha Kolloju, Co-founder, Heamac Healthcare Pvt. Ltd has have been awarded BIRAC TiE WInER Award 2019 for Women in Entrepreneurial Researcb. The award ceremony was held on BIRAC’s 7th Foundation Day, 19 March 2019 at New Delhi

SUPPORTED BY

CONTACT US

We’d love to hear from you! Please send us a message if you have questions or comments for us.